应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMRN Immuron Ltd
休市中 07-11 16:00:00 EDT
1.74
-0.02
-1.42%
盘后
1.71
-0.03
-1.72%
17:35 EDT
最高
1.78
最低
1.70
成交量
1.84万
今开
1.77
昨收
1.77
日振幅
4.53%
总市值
1,018万
流通市值
1,005万
总股本
584.90万
成交额
3.23万
换手率
0.32%
流通股本
577.78万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Immuron Limited盘中异动 股价大跌6.08%
市场透视 · 07-07
Immuron Limited盘中异动 股价大跌6.08%
Immuron Limited盘中异动 股价大跌5.41%
市场透视 · 06-30
Immuron Limited盘中异动 股价大跌5.41%
Immuron Limited盘中异动 大幅拉升5.74%
市场透视 · 06-24
Immuron Limited盘中异动 大幅拉升5.74%
Immuron Limited盘中异动 临近收盘股价大涨6.16%
市场透视 · 06-20
Immuron Limited盘中异动 临近收盘股价大涨6.16%
Immuron Limited盘中异动 早盘急速跳水5.62%
市场透视 · 06-17
Immuron Limited盘中异动 早盘急速跳水5.62%
Immuron Limited盘中异动 早盘股价大涨5.92%报1.79美元
市场透视 · 06-10
Immuron Limited盘中异动 早盘股价大涨5.92%报1.79美元
Immuron Limited盘中异动 急速拉升5.88%
市场透视 · 06-06
Immuron Limited盘中异动 急速拉升5.88%
Immuron Limited盘中异动 早盘急速上涨6.15%
市场透视 · 06-03
Immuron Limited盘中异动 早盘急速上涨6.15%
Immuron Limited盘中异动 早盘股价大跌10.93%
市场透视 · 05-30
Immuron Limited盘中异动 早盘股价大跌10.93%
Immuron Limited盘中异动 股价大涨5.81%
市场透视 · 05-21
Immuron Limited盘中异动 股价大涨5.81%
Immuron Limited盘中异动 下午盘股价大跌6.35%
市场透视 · 05-19
Immuron Limited盘中异动 下午盘股价大跌6.35%
Immuron Limited盘中异动 股价大涨6.38%
市场透视 · 05-16
Immuron Limited盘中异动 股价大涨6.38%
Immuron Limited盘中异动 早盘股价大跌7.37%报1.76美元
市场透视 · 05-15
Immuron Limited盘中异动 早盘股价大跌7.37%报1.76美元
Immuron Limited盘中异动 股价大涨9.42%报2.09美元
市场透视 · 05-12
Immuron Limited盘中异动 股价大涨9.42%报2.09美元
Immuron Limited盘中异动 急速拉升5.62%报1.97美元
市场透视 · 04-30
Immuron Limited盘中异动 急速拉升5.62%报1.97美元
Immuron Limited盘中异动 早盘快速拉升6.54%报1.91美元
市场透视 · 04-28
Immuron Limited盘中异动 早盘快速拉升6.54%报1.91美元
Immuron Limited盘中异动 快速拉升8.42%
市场透视 · 04-24
Immuron Limited盘中异动 快速拉升8.42%
Immuron Limited盘中异动 急速拉升6.25%报1.78美元
市场透视 · 04-22
Immuron Limited盘中异动 急速拉升6.25%报1.78美元
Immuron Limited盘中异动 早盘快速跳水7.02%报1.76美元
市场透视 · 04-21
Immuron Limited盘中异动 早盘快速跳水7.02%报1.76美元
Immuron Limited盘中异动 股价大涨5.88%报1.80美元
市场透视 · 04-14
Immuron Limited盘中异动 股价大涨5.88%报1.80美元
加载更多
公司概况
公司名称:
Immuron Ltd
所属市场:
NASDAQ
上市日期:
--
主营业务:
Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司,拥有一个专利技术平台,专注于开发和商业化一类新型的特异性靶向多克隆抗体,公司相信这种抗体能够解决严重的未满足医疗需求。
发行价格:
--
{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":1.74,"timestamp":1752264000000,"preClose":1.765,"halted":0,"volume":18428,"hourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.74,"latestTime":"17:35 EDT","volume":1350,"amount":2464.5,"timestamp":1752269731245},"delay":0,"floatShares":5777833,"shares":5848975,"eps":-0.797723,"marketStatus":"休市中","change":-0.025,"latestTime":"07-11 16:00:00 EDT","open":1.77,"high":1.78,"low":1.7,"amount":32345.5774624,"amplitude":0.045326,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.797723,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":1,"adrRate":40,"exchange":"NASDAQ","adjPreClose":1.765,"preHourTrading":{"tag":"盘前","latestPrice":1.88,"preClose":1.765,"latestTime":"08:00 EDT","volume":148,"amount":278.24,"timestamp":1752235207550},"postHourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.74,"latestTime":"17:35 EDT","volume":1350,"amount":2464.5,"timestamp":1752269731245},"volumeRatio":1.8263265129373867},"requestUrl":"/m/hq/s/IMRN","defaultTab":"news","newsList":[{"id":"2549559475","title":"Immuron Limited盘中异动 股价大跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559475?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:10","pubTimestamp":1751904657,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时10分,Immuron Limited股票出现波动,股价大幅下挫6.08%。截至发稿,该股报1.67美元/股,成交量4642股,换手率0.08%,振幅2.25%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.54%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001057a69b4f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001057a69b4f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2548459011","title":"Immuron Limited盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548459011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548459011?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:56","pubTimestamp":1751302594,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日00时56分,Immuron Limited股票出现异动,股价快速跳水5.41%。截至发稿,该股报1.75美元/股,成交量2.0344万股,换手率0.36%,振幅7.57%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.22%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005634a7268f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005634a7268f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2545231524","title":"Immuron Limited盘中异动 大幅拉升5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545231524?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:31","pubTimestamp":1750779073,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时31分,Immuron Limited股票出现异动,股价快速上涨5.74%。截至发稿,该股报1.94美元/股,成交量3.7497万股,换手率0.65%,振幅6.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为1.70%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624233113a71b7d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624233113a71b7d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2545772901","title":"Immuron Limited盘中异动 临近收盘股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545772901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545772901?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:38","pubTimestamp":1750448317,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时38分,Immuron Limited股票出现异动,股价快速上涨6.16%。截至发稿,该股报1.83美元/股,成交量3.4937万股,换手率0.61%,振幅3.05%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.61%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033838a7151367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033838a7151367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2544998461","title":"Immuron Limited盘中异动 早盘急速跳水5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544998461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544998461?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:41","pubTimestamp":1750167663,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时41分,Immuron Limited股票出现异动,股价快速下挫5.62%。截至发稿,该股报1.68美元/股,成交量1231股,换手率0.02%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.65%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214103a70e7430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617214103a70e7430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2542310378","title":"Immuron Limited盘中异动 早盘股价大涨5.92%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542310378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542310378?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:32","pubTimestamp":1749562349,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时32分,Immuron Limited股票出现异动,股价急速拉升5.92%。截至发稿,该股报1.79美元/股,成交量1226股,换手率0.02%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.40%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213229a702391e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213229a702391e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2541863512","title":"Immuron Limited盘中异动 急速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863512?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:30","pubTimestamp":1749216645,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时30分,Immuron Limited股票出现异动,股价快速拉升5.88%。截至发稿,该股报1.80美元/股,成交量320股,换手率0.01%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.00%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062130459774709b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062130459774709b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2540777831","title":"Immuron Limited盘中异动 早盘急速上涨6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777831?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:33","pubTimestamp":1748957602,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时33分,Immuron Limited股票出现异动,股价大幅上涨6.15%。截至发稿,该股报1.87美元/股,成交量2053股,换手率0.04%,振幅6.15%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.61%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213322a4985f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213322a4985f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2539227802","title":"Immuron Limited盘中异动 早盘股价大跌10.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539227802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539227802?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:30","pubTimestamp":1748611826,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时30分,Immuron Limited股票出现异动,股价大幅跳水10.93%。截至发稿,该股报1.63美元/股,成交量3806股,换手率0.07%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.00%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213026976b3445&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213026976b3445&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2537930359","title":"Immuron Limited盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537930359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537930359?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:20","pubTimestamp":1747844437,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时20分,Immuron Limited股票出现波动,股价大幅上涨5.81%。截至发稿,该股报1.70美元/股,成交量4232股,换手率0.07%,振幅4.84%。Immuron Limited股票所在的生物技术行业中,整体跌幅为0.34%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002037aa2c959f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002037aa2c959f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2536634530","title":"Immuron Limited盘中异动 下午盘股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536634530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536634530?lang=zh_cn&edition=full","pubTime":"2025-05-20 01:47","pubTimestamp":1747676872,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日01时47分,Immuron Limited股票出现异动,股价快速下跌6.35%。截至发稿,该股报1.60美元/股,成交量2206股,换手率0.04%,振幅5.53%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.34%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520014753a6e50606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520014753a6e50606&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2535125453","title":"Immuron Limited盘中异动 股价大涨6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535125453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535125453?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:51","pubTimestamp":1747407066,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时51分,Immuron Limited股票出现异动,股价大幅上涨6.38%。截至发稿,该股报1.81美元/股,成交量105股,换手率0.00%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.42%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516225106a4810a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516225106a4810a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2535290468","title":"Immuron Limited盘中异动 早盘股价大跌7.37%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535290468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535290468?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:51","pubTimestamp":1747317103,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时51分,Immuron Limited股票出现异动,股价大幅下挫7.37%。截至发稿,该股报1.76美元/股,成交量1493股,换手率0.03%,振幅1.05%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.31%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521514394f7feb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051521514394f7feb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2535120405","title":"Immuron Limited盘中异动 股价大涨9.42%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535120405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535120405?lang=zh_cn&edition=full","pubTime":"2025-05-13 00:32","pubTimestamp":1747067560,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日00时32分,Immuron Limited股票出现异动,股价快速拉升9.42%。截至发稿,该股报2.09美元/股,成交量5947股,换手率0.10%,振幅3.14%。Immuron Limited股票所在的生物技术行业中,整体涨幅为3.32%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051300324094f4a802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051300324094f4a802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2531763055","title":"Immuron Limited盘中异动 急速拉升5.62%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531763055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531763055?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:52","pubTimestamp":1746021173,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时52分,Immuron Limited股票出现异动,股价快速拉升5.62%。截至发稿,该股报1.97美元/股,成交量1.2743万股,换手率0.22%,振幅1.61%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.34%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215253aa2c7f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215253aa2c7f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2530238651","title":"Immuron Limited盘中异动 早盘快速拉升6.54%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530238651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530238651?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:27","pubTimestamp":1745850462,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时27分,Immuron Limited股票出现波动,股价急速上涨6.54%。截至发稿,该股报1.91美元/股,成交量68股,换手率0.00%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为1.24%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822274297489ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822274297489ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2530269951","title":"Immuron Limited盘中异动 快速拉升8.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530269951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530269951?lang=zh_cn&edition=full","pubTime":"2025-04-24 23:56","pubTimestamp":1745510161,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日23时56分,Immuron Limited股票出现波动,股价快速上涨8.42%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.61%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424235601a6c6d239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424235601a6c6d239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2529558034","title":"Immuron Limited盘中异动 急速拉升6.25%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529558034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529558034?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:35","pubTimestamp":1745328928,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时35分,Immuron Limited股票出现异动,股价快速拉升6.25%。截至发稿,该股报1.78美元/股,成交量255股,换手率0.00%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.81%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213528aa2c75f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213528aa2c75f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2529894483","title":"Immuron Limited盘中异动 早盘快速跳水7.02%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529894483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529894483?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:15","pubTimestamp":1745248521,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时15分,Immuron Limited股票出现波动,股价急速下挫7.02%。截至发稿,该股报1.76美元/股,成交量1027股,换手率0.02%,振幅0.00%。Immuron Limited股票所在的生物技术行业中,整体涨幅为0.12%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421231521a6c28bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421231521a6c28bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2527148455","title":"Immuron Limited盘中异动 股价大涨5.88%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527148455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527148455?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:00","pubTimestamp":1744657217,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时00分,Immuron Limited股票出现波动,股价快速拉升5.88%。截至发稿,该股报1.80美元/股,成交量7249股,换手率0.13%,振幅12.92%。Immuron Limited股票所在的生物技术行业中,整体涨幅为2.70%。Immuron Limited公司简介:Immuron Ltd 是一家商业和临床阶段的生物制药公司,专注于开发和商业化一类新型免疫调节剂多克隆抗体,用于治疗肝病、传染病和其他免疫介导疾病,如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415030017a6ba58bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415030017a6ba58bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0235},{"period":"6month","weight":-0.1077},{"period":"1year","weight":-0.2411},{"period":"ytd","weight":0.0235}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司,拥有一个专利技术平台,专注于开发和商业化一类新型的特异性靶向多克隆抗体,公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.232349},{"month":2,"riseRate":0.125,"avgChangeRate":-0.076005},{"month":3,"riseRate":0.375,"avgChangeRate":0.023659},{"month":4,"riseRate":0.375,"avgChangeRate":0.002971},{"month":5,"riseRate":0.125,"avgChangeRate":-0.099969},{"month":6,"riseRate":0.428571,"avgChangeRate":0.327208},{"month":7,"riseRate":0.5,"avgChangeRate":0.028387},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.018746},{"month":9,"riseRate":0.375,"avgChangeRate":-0.070912},{"month":10,"riseRate":0.125,"avgChangeRate":-0.095831},{"month":11,"riseRate":0.5,"avgChangeRate":0.037295},{"month":12,"riseRate":0.125,"avgChangeRate":-0.092727}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}